Epigenetics in pharmacogenes encoding metabolizing enzymes of second-generation antipsychotics used in schizophrenia and its clinical implications

Schizophrenia is a neuropsychiatric disorder caused by neurochemical alterations, non-genetic, genetic, epigenetic and environmental factors. Pharmacoepigenetics studies the relationship between epigenetic variability and response to drugs. The objective was to realize a descriptive review of the cu...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Angel T. Alvarado, Amparo Iris Zavaleta, César Li-Amenero, María R. Bendezú, Jorge A. Garcia, Haydee Chávez, Juan J. Palomino-Jhong, Felipe Surco-Laos, Doris Laos-Anchante, Elizabeth J. Melgar-Merino, Mario Bolarte-Arteaga, Nesquen Tasayco-Yataco, Ricardo Pariona-Llanos
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-09-01
Saila:	Frontiers in Pharmacology
Gaiak:	epigenetics pharmacogenes schizophrenia antipsychotic drugs clinical implications
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1611203/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!